Cargando…
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
There are currently approximately 4000 mutations in the SARS-CoV-2 S protein gene and emerging SARS-CoV-2 variants continue to spread rapidly worldwide. Universal vaccines with high efficacy and safety urgently need to be developed to prevent SARS-CoV-2 variants pandemic. Here, we described a novel...
Autores principales: | Qin, Shugang, Huang, Hai, Xiao, Wen, Chen, Kepan, He, Xi, Tang, Xiaoshan, Huang, Zhiying, Zhang, Yupei, Duan, Xing, Fan, Na, Zheng, Qian, Wu, Min, Lu, Guangwen, Wei, Yuquan, Wei, Xiawei, Song, Xiangrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833852/ https://www.ncbi.nlm.nih.gov/pubmed/36647424 http://dx.doi.org/10.1016/j.apsb.2023.01.010 |
Ejemplares similares
-
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
por: Duan, Xing, et al.
Publicado: (2023) -
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
por: Chen, Kepan, et al.
Publicado: (2022) -
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022) -
mRNA-based therapeutics: powerful and versatile tools to combat diseases
por: Qin, Shugang, et al.
Publicado: (2022) -
Long-timescale dynamics of the Drew–Dickerson dodecamer
por: Dans, Pablo D., et al.
Publicado: (2016)